regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Centers for Disease Control and Prevention, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Cross-Sector story that mention Candida auris, all published on February 27, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Candida auris
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Centers for Disease Control and Prevention, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Cross-Sector story that mention Candida auris, all published on February 27, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Candida auris. Shared-story counts are live from our verified record — not editorial picks.
New York health officials have issued a high-priority alert regarding the rapid spread of highly drug-resistant fungal infections across the state's healthcare infrastructure. These pathogens, including Candida auris, pose a severe threat to immunocompromised patients and are increasingly evading standard antifungal treatments.